Picture of Biosenic SA logo

BIOS Biosenic SA News Story

0.000.00%
be flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Brief: Bone Therapeutics Net Cash At End-March Amounts To EUR 8.5 Million

May 26 (Reuters) - Bone Therapeutics SA  BOTHE.BR :
    * REG-BONE THERAPEUTICS PROVIDES FIRST QUARTER 2021 BUSINESS
UPDATE
    * NET CASH AT END OF MARCH 2021 AMOUNTED TO EUR 8.5 MILLION
    * NET CASH BURN FOR FULL YEAR 2021 IS EXPECTED TO BE IN
RANGE OF
EUR 16-17 MILLION
    * COMPANY IS CURRENTLY EVALUATING AND WORKING ON DIFFERENT
FINANCING OPTIONS AND PLANS TO RAISE NEW FUNDS WITH A FOCUS ON
NON-DILUTIVE FUNDING STRATEGIES
    * ANTICIPATES HAVING SUFFICIENT CASH TO CARRY OUT ITS
BUSINESS
OBJECTIVES INTO NOVEMBER 2021

Source text for Eikon:  ID:nGNE3B2zvy 
Further company coverage:  BOTHE.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Biosenic SA

See all news